Hint mode is switched on Switch off
For swift navigation between sections

Mallinckrodt International Finance
LEI 549300MQQ92LN1A0B514

The issuer's bonds defaulted in 2023
Organization name
Mallinckrodt International Finance S.A.
Country name
Switzerland
Country of registration
Luxembourg
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
1,873 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Mallinckrodt International Finance S.A., through its subsidiaries, develops medicines and other pharmaceutical products. Mallinckrodt International Finance S.A. was incorporated in 2012 and is based in Luxembourg. Mallinckrodt International Finance S.A. operates as a subsidiary of Mallinckrodt Public Limited Company.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    549300MQQ92LN1A0B514
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001594034
Registration is required to get access.